These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 4170754)

  • 1. Bacterial precipitins in serum of patients with cystic fibrosis.
    Burns MW; May JR
    Lancet; 1968 Feb; 1(7537):270-2. PubMed ID: 4170754
    [No Abstract]   [Full Text] [Related]  

  • 2. Pseudomonas aeruginosa infection in cystic fibrosis. Occurrence of precipitating antibodies against pseudomonas aeruginosa in relation to the concentration of sixteen serum proteins and the clinical and radiographical status of the lungs.
    Hoiby N; Jacobsen L; Jorgensen BA; Lykkegaard E; Weeke B
    Acta Paediatr Scand; 1974 Nov; 63(6):843-8. PubMed ID: 4215280
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bacteriological characteristics of chronic bronchial infections].
    May JR
    Poumon Coeur; 1973; 29(4):425-8. PubMed ID: 4211172
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemophilus influenzae, Staphylococcus aureus, Pseudomonas cepacia, and Pseudomonas aeruginosa in patients with cystic fibrosis.
    Høiby N
    Chest; 1988 Aug; 94(2 Suppl):97S-103S. PubMed ID: 3293941
    [No Abstract]   [Full Text] [Related]  

  • 5. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis.
    Hoiby N; Flensborg EW; Beck B; Friis B; Jacobsen SV; Jacobsen L
    Scand J Respir Dis; 1977 Apr; 58(2):65-79. PubMed ID: 404701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial infection in cystic fibrosis.
    May JR; Herrick NC; Thompson D
    Arch Dis Child; 1972 Dec; 47(256):908-13. PubMed ID: 4630478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial precipitins and autoantibodies in serum of patients with cystic fibrosis.
    Høiby N; Wiik A
    Scand J Respir Dis; 1975 May; 56(1):38-46. PubMed ID: 238280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary infection in cystic fibrosis.
    Friend PA
    J Infect; 1986 Jul; 13(1):55-72. PubMed ID: 3090153
    [No Abstract]   [Full Text] [Related]  

  • 9. Bacterial flora of respiratory tract in patients with cystic fibrosis, 1950-71.
    Mearns MB; Hunt GH; Rushworth R
    Arch Dis Child; 1972 Dec; 47(256):902-7. PubMed ID: 4630477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa infection in cystic fibrosis. Relative prevalence of antibodies in serum against cathodic and anodic migrating P. aeruginosa antigens determined by immunoelectrophoretic methods.
    Holby N
    Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):149-52. PubMed ID: 67746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial therapy in cystic fibrosis. A review of the literature published between 1980 and February 1987.
    Michel BC
    Chest; 1988 Aug; 94(2 Suppl):129S-140S. PubMed ID: 3293939
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pseudomonas aeruginosa antibodies in patients with cystic fibrosis: clinical implications].
    Marianelli L; Campana S; Taccetti G; Gabbrielli M; Dei R
    Pediatr Med Chir; 1994; 16(6):551-4. PubMed ID: 7708538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precipitating antibodies against Haemophilus influenzae and Staphylococcus aureus in sputum and serum from patients with cystic fibrosis.
    Schiøtz PO; Høiby N
    Acta Pathol Microbiol Scand B; 1979 Dec; 87(6):345-51. PubMed ID: 317211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between mucoid strains of Pseudomonas aeruginosa and the humoral immune response.
    Hoiby N
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):551-8. PubMed ID: 4213330
    [No Abstract]   [Full Text] [Related]  

  • 15. Precipitating Pseudomonas aeruginosa antibodies and antimicrobial therapy in cystic fibrosis patients.
    Trancassini M; de Vito D; Cimino G; Antonelli M; Quattrucci S; Cipriani P
    Eur J Clin Microbiol Infect Dis; 1996 Apr; 15(4):309-12. PubMed ID: 8781882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey.
    Hoiby N
    Acta Pathol Microbiol Scand Suppl; 1977; (262):1-96. PubMed ID: 411327
    [No Abstract]   [Full Text] [Related]  

  • 17. Prospective study of serum staphylococcal antibodies in cystic fibrosis.
    Hollsing AE; Granström M; Strandvik B
    Arch Dis Child; 1987 Sep; 62(9):905-11. PubMed ID: 3118820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bacteriologic examination of bronchoscopic samples in nontubercular lung diseases in children].
    Wiesner B; Langmann I
    Bronches; 1968; 18(2):124-30. PubMed ID: 4386477
    [No Abstract]   [Full Text] [Related]  

  • 19. Pseudomonas aeruginosa infection and cystic fibrosis.
    Kato K; Takayama T
    Lancet; 2002 Jan; 359(9302):262. PubMed ID: 11812595
    [No Abstract]   [Full Text] [Related]  

  • 20. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis.
    Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
    BMC Infect Dis; 2017 Jun; 17(1):411. PubMed ID: 28599639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.